New York, NY -- (SBWIRE) -- 01/16/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Ballard Power Systems Inc. (USA) (NASDAQ:BLDP), AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), XOMA Corp (NASDAQ:XOMA), Quicksilver Resources Inc (NYSE:KWK)
Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) showed a volume of 1.94 million shares by the end of last trade whereas the average volume of the stock remained 3.86 million shares. The stock opened the session at $2.30 but then moved to $2.36. At that price, the stock showed a positive performance of 2.61%. Ballard Power Systems Inc. (Ballard) is engaged in design, development, manufacture, sale and service of fuel cell products for a variety of applications, focusing on motive power (material handling and buses) and stationary power (back-up power and distributed generation). It is also engaged in proton exchange membrane (PEM) fuel cell development and commercialization.
Will BLDP Continue To Move Higher? Find Out Here
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) opened the session at $1.26 and closed the session at $1.29. The stock showed a positive performance of 1.57% in previous trading session. Traded with volume of 1.94 million shares in the prior session and the average volume of the stock remained 2.70 million shares. Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrine therapy. The Company’s pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. The development priorities in oncology are the completion of Phase 3 trials with perifosine in colorectal cancer (CRC) and in multiple myeloma (MM),
For How Long AEZS will fight for Profitability? Read This Trend Analysis report
XOMA Corp (NASDAQ:XOMA) opened the session at $8.55 and closed the session at $8.19. The stock showed a negative performance of 1-1.56% in previous trading session. Traded with volume of 1.88 million shares in the prior session and the average volume of the stock remained 12.95 million shares. The beta of the stock remained 2.41. XOMA Corporation (XOMA) is engaged in the discovery and development of antibody-based therapeutics. The Company’s lead drug candidate is gevokizumab (formerly XOMA 052), a humanized monoclonal allosteric modulating antibody designed to inhibit the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta).
Why Should Investors Buy XOMA After the Recent Fall? Just Go Here and Find Out
Quicksilver Resources Inc (NYSE:KWK) traded with volume of 1.88 million shares in the prior session and the average volume of the stock remained 3.91 million shares. The beta of the stock remained 1.45. Quicksilver Resources Inc. is an independent oil and gas company engaged primarily in the acquisition, exploration, development and production of onshore oil and gas in North America and are based in Fort Worth, Texas. The Company is focused primarily on unconventional reservoirs where hydrocarbons may be found in geological conditions, such as fractured shales and coalbeds.
Is KWK a Solid Investment at These Levels? Read This Report For Details
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)